Stockreport

Fluidigm CyTOF Technology Used to Evaluate Stem Cell Therapy as a Potential Treatment for COVID-19 Pneumonia

Fluidigm Corporation  (FLDM) 
Last fluidigm corporation earnings: 2/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.fluidigm.com
PDF SOUTH SAN FRANCISCO, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve [Read more]